Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 138   

Articles published

GSK 1,476.00 +16.00 (1.10%)
price chart
Traders See Bearish Options Activity GlaxoSmithKline plc (ADR)
In today's session GlaxoSmithKline plc (ADR) (GSK) recorded an unusually high (1,600) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the May, 2017 put, expecting serious GSK decrease.
The Financial Advisory Service Inc. invests in 258 by purchasing ...  DailyQuint
What Analyst Expect from Stocks? GlaxoSmithKline PLC (NYSE:GSK) , Rexahn ...  Is stories
GlaxoSmithKline plc 23.5% Potential Upside Indicated by JP Morgan Cazenove
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK has had its stock rating noted as 'Retains' with the recommendation being set at 'NEUTRAL' this morning by analysts at JP Morgan Cazenove.
The Goldman Sachs Group Inc. Reiterates “Buy” Rating for GlaxoSmithKline PLC ...  DailyQuint
Important Rating: Professional Analysts at JP Morgan Cazenove Didn't ...  Thorold News
Stock Perspective: GlaxoSmithKline PLC (NYSE:GSK) Company Earnings Watch
When a company reports earnings, the reports are intensely examined by investors and analysts alike. Earnings are important because they can give insight into the profitability of a company.
Better buy: GlaxoSmithKline plc vs Shire plc
On the face of it, GlaxoSmithKline (LSE: GSK) and Shire (LSE: SHP) are both very similar; large, globe-spanning pharmaceutical companies with cutting-edge treatments for a range of diseases.
Analyst Targets on GlaxoSmithKline PLC (NYSE:GSK) Underscore Where the Stock ...
Wall Street analysts covering GlaxoSmithKline PLC (NYSE:GSK) shares are predicting that the stock will trade between $47.5 and $49 within the next year.
The Next Wonder Stock? OTC Stock: GLAXOSMITHKLINE PLC (GLAXF)
GLAXOSMITHKLINE PLC (GLAXF)'s shares have earned a closer look from OTC investors due to the fact that the stock's price shifted -0.11, acheiving a $18.19 price point upon recent trading.
GlaxoSmithKline plc's (GSK) "Neutral" Rating Reiterated at JPMorgan Chase & Co.
Finally, Goldman Sachs Group Inc. reissued a buy rating and issued a GBX 1,800 ($22.87) price objective on shares of GlaxoSmithKline plc in a research note on Tuesday, September 20th. Two investment analysts have rated the stock with a sell rating, ...
JPMorgan Chase & Co. Reiterates "Neutral" Rating for ...  BBNS
What's Next for WPP PLC ORD 10P After Today's Huge Decline?  Frisco Fastball
Worth Watching Stocks: salesforce.com, inc. (NYSE:CRM), GlaxoSmithKline plc ...
Salesforce.com is the market and technology leader in on-demand business services. The company's Salesforce suite of on-demand CRM applications allows customers to manage and share all of their sales, support, marketing and partner information ...
Market Fallers: Fresnillo Plc, GKN plc, Glencore PLC, GlaxoSmithKline plc
The share price for Fresnillo Plc company symbol: LON:FRES has declined -4.17% or -50 points during today's session so far.
GlaxoSmithKline plc (GSK) Given "Buy" Rating at Goldman Sachs ...  Community Financial News
Today: Today: GlaxoSmithKline plc (GSK) PT Raised to GBX 1950 at Jefferies Group  DailyQuint
GlaxoSmithKline plc's (GSK): Market Traders Alert
GlaxoSmithKline plc's (GSK) ended its day with a loss of -0.37% and finalized at the price of $37.55. During its last trading session, Stock traded with the total exchanged volume of 4.98 million shares.
Today's Market Runner: GlaxoSmithKline plc (ADR) Can't Be More Risky ...  Frisco Fastball
GlaxoSmithKline plc's (GSK) "Neutral" Rating Reaffirmed at ...  The Cerbat Gem